Description
An SCD inhibitor (IC50 = 6.1 nM in HepG2 cells); dose-dependently reduces levels of palmitoleic acid and vaccenic acid in the plasma and liver of rats fed a high-sucrose diet; reduces hepatic triglyceride levels in sucrose-fed rats at 20 mg/kg
Formal name: 2-hydroxy-N-[2-[3-methyl-2-oxo-7-[[[3-(trifluoromethyl)phenyl]methyl]amino]-1(2H)-quinoxalinyl]ethyl]-acetamide
Synonyms:
Molecular weight: 434.4
CAS: 1018675-35-8
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Dyslipidemias